Introduction: The cardio-ankle vascular index (CAVI) is a well-known index to evaluate arterial stiffness and predict cardiovascular risk. Methods: We investigated whether CAVI can predict severity and extent of peripheral arterial disease. This study was a single-center, retrospective, observational study approved by the Ethics Committee of Yokohama Shintoshi Neurosurgical Hospital. A total of 96 patients (males, 63) with an abnormal ankle-brachial blood pressure index (ABI) of <0.9 and who underwent extremity arteriography at our hospital from 2015 to 2018 were enrolled in this study. We defined that CAVI with a range of <8.0 was normal. Results: Coronary angiography and extremity arteriography were performed for patients who had intermittent claudication and abnormal ABI. We divided the affected limbs into 3 categories: above-the-knee artery stenosis, above-the-knee artery chronic total occlusion, and only below-the-knee artery stenosis/occlusion groups. CAVI pseudonormalization was seen in 28, 76, and 19%, respectively. The above-the-knee artery stenosis and the only below-the-knee artery stenosis/occlusion groups had a high odds ratio of abnormalization of CAVI (3.1, 95% confidence interval [CI]: 1.39–7.22; p = 0.05, 4.56, 95% CI: 1.64–14.7). Discussion/Conclusion: In the presence of the above-the-knee artery chronic total occlusion, CAVI pseudonormalization was likely to be seen. The presence of CTO in the above-the-knee artery is one cause of pseudonormalized CAVI. In the range of ABI, in which stenotic lesions and obstructive lesions coexist, it may be possible to detect the existence of CTO by a combination of both ABI and CAVI.

1.
Greenland
P
,
Smith
SC
 Jr
,
Grundy
SM
.
Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests
.
Circulation
.
2001
;
104
:
1863
7
. .
2.
Ankle Brachial Index Collaboration
;
Fowkes
FG
,
Fowkes
FG
,
Murray
GD
,
Butcher
I
,
Heald
CL
,
Lee
RJ
,
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis
.
JAMA
.
2008
;
300
:
197
208
. .
3.
Tomiyama
H
,
Matsumoto
C
,
Shiina
K
,
Yamashina
A
.
Brachial-Ankle PWV: current status and future directions as a useful marker in the management of cardiovascular disease and/or cardiovascular risk factors
.
J Atheroscler Thromb
.
2016
;
23
:
128
46
. .
4.
Martyn
CN
,
Gale
CR
,
Jespersen
S
,
Sherriff
SB
.
Impaired fetal growth and atherosclerosis of carotid and peripheral arteries
.
Lancet
.
1998
;
352
:
173
8
. .
5.
Busch
MA
,
Lutz
K
,
Röhl
JE
,
Neuner
B
,
Masuhr
F
.
Low ankle-brachial index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack
.
Stroke
.
2009
;
40
:
3700
5
. .
6.
Kajikawa
M
,
Maruhashi
T
,
Iwamoto
Y
,
Iwamoto
A
,
Matsumoto
T
,
Hidaka
T
,
Borderline ankle-brachial index value of 0.91–0.99 is associated with endothelial dysfunction
.
Circ J
.
2014
;
78
:
1740
5
.
7.
Gerhard-Herman
MD
,
Gornik
HL
,
Barrett
C
,
Barshes
NR
,
Corriere
MA
,
Drachman
DE
,
2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
.
Circulation
.
2017
;
135
:
e726
79
.
8.
Gerhard-Herman
MD
,
Gornik
HL
,
Barrett
C
,
Barshes
NR
,
Corriere
MA
,
Drachman
DE
,
2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
.
Circulation
.
2017
;
135
:
e726
79
.
9.
US Centers for Disease Control and Prevention [updated 2013 May 8; cited 2014 January 11]. Available from: https://www.cdc.gov/.
10.
Sun
CK
.
Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness
.
Integr Blood Press Control
.
2013
;
6
:
27
38
. .
11.
Nakamura
K
,
Tomaru
T
,
Yamamura
S
,
Miyashita
Y
,
Shirai
K
,
Noike
H
.
Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis
.
Circ J
.
2008
;
72
:
598
604
. .
12.
Saiki
A
,
Sato
Y
,
Watanabe
R
,
Watanabe
Y
,
Imamura
H
,
Yamaguchi
T
,
The role of a novel arterial stiffness parameter, Cardio-Ankle Vascular Index (CAVI), as a surrogate marker for cardiovascular diseases
.
J Atheroscler Thromb
.
2016
;
23
:
155
68
. .
13.
Takaki
A
,
Ogawa
H
,
Wakeyama
T
,
Iwami
T
,
Kimura
M
,
Hadano
Y
,
Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness
.
Hypertens Res
.
2008
;
31
:
1347
55
. .
14.
Shirai
K
.
Analysis of vascular function using the cardio-ankle vascular index (CAVI)
.
Hypertens Res
.
2011
;
34
:
684
5
. .
15.
Horinaka
S
,
Yabe
A
,
Yagi
H
,
Ishimura
K
,
Hara
H
,
Iemura
T
,
Cardio-ankle vascular index could reflect plaque burden in the coronary artery
.
Angiology
.
2011
;
62
:
401
8
. .
16.
Saji
N
,
Kimura
K
,
Shimizu
H
,
Kita
Y
.
Silent brain infarct is independently associated with arterial stiffness indicated by cardio-ankle vascular index (CAVI)
.
Hypertens Res
.
2012
;
35
:
756
60
. .
17.
Asmar
R
.
Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index
.
Eur Heart J
.
2017
;
19
(
Suppl l_B
):
B4
10
. .
18.
Ato
D
.
Brachial-ankle pulse wave velocity, cardio-ankle vascular index, and prognosis
.
Vasc Health Risk Manag
.
2018
;
14
:
321
48
. .
19.
Alpert
JS
.
Cardiology patient page: What you need to know if you have coronary artery disease
.
Circulation
.
2011
;
124
:
e176
e178
.
20.
Sato
Y
,
Nagayama
D
,
Saiki
A
,
Watanabe
R
,
Watanabe
Y
,
Imamura
H
,
Cardio-ankle vascular index is independently associated with future cardiovascular events in outpatients with metabolic disorders
.
J Atheroscler Thromb
.
2016
;
23
:
596
605
. .
21.
Park
JB
,
Park
HE
,
Choi
SY
,
Kim
MK
,
Oh
BH
.
Relation between cardio-ankle vascular index and coronary artery calcification or stenosis in asymptomatic subjects
.
J Atheroscler Thromb
.
2013
;
20
:
557
67
. .
22.
Hu
H
,
Cui
H
,
Han
W
,
Ye
L
,
Qiu
W
,
Yang
H
,
A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis
.
Hypertens Res
.
2013
;
36
:
334
41
. .
23.
Nishizawa
Y
,
Shoji
T
,
Maekawa
K
,
Nagasue
K
,
Okuno
S
,
Kim
M
,
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients
.
Am J Kidney Dis
.
2003
;
41
:
S76
9
. .
24.
Shirai
K
,
Utino
J
,
Otsuka
K
,
Takata
M
.
A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI)
.
J Atheroscler Thromb
.
2006
;
13
:
101
7
. .
25.
Gerhard-Herman
MD
,
Gornik
HL
,
Barrett
C
,
Barshes
NR
,
Corriere
MA
,
Drachman
DE
,
2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
.
Circulation
.
2017
;
135
:
e686
725
. .
26.
Srinubab
G
,
Allam
AR
,
Narashima
RM
.
Identification of biomarkers for type 2 diabetes and its complications: a bioinformatic approach
.
Int J Biomed Sci
.
2007
;
3
:
229
36
.
27.
Kanda
Y
.
Investigation of the freely available easy-to-use software “EZR” for medical statistics
.
Bone Marrow Transplant
.
2013
;
48
:
452
8
.
28.
Kirigaya
J
,
Iwahashi
N
,
Tahakashi
H
,
Minamimoto
Y
,
Gohbara
M
,
Abe
T
,
Impact of cardio-ankle vascular index on long-term outcome in patients with acute coronary syndrome
.
Atheroscler Thromb
.
2019
;
26
:
15409
.
29.
Park
JB
,
Park
HE
,
Choi
SY
,
Kim
MK
,
Oh
BH
.
Relation between cardio-ankle vascular index and coronary artery calcification or stenosis in asymptomatic subjects
.
J Atheroscler Thromb
.
2013
;
20
:
557
67
. .
30.
Bhatt
DL
,
Eagle
KA
,
Ohman
EM
,
Hirsch
AT
,
Goto
S
,
Mahoney
EM
,
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis
.
JAMA
.
2010
;
304
:
1350
7
. .
31.
Orchard
TJ
,
Strandness
DE
 Jr
.
Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana
.
Circulation
.
1993
;
88
:
819
28
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.